Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Avita Medical Inc. (RCEL : NSDQ)

• Company Description    AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif. Number of Employees: 260

• Price / Volume Information    Yesterday's Closing Price: $3.77 Daily Weekly Monthly 20 Day Moving Average: 263,143 shares Shares Outstanding: 26.62 (millions) Market Capitalization: $100.35 (millions) Beta: 1.58 52 Week High: $14.16 52 Week Low: $3.36 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -26.65% -28.58% 12 Week -33.04% -35.81% Year To Date -70.55% -74.25%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 28159 Avenue Stanford Suite 220 - Valencia,CA 91355 USA ph: 661-367-9170 fax: - investor@avitamedical.com http://www.avitamedical.com

• General Corporate Information    Officers James Corbett - Chief Executive Officer and Executive Director Lou Panaccio - Chairman of the Board of Directors David O'Toole - Chief Financial Officer Jeremy Curnock Cook - Director Suzanne Crowe - Director Peer Information Avita Medical Inc. (GSAC) Avita Medical Inc. (CASI) Avita Medical Inc. (ALCD.) Avita Medical Inc. (OMNN) Avita Medical Inc. (CGPI.) Avita Medical Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 05380C102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/12/26 Share - Related Items Shares Outstanding: 26.62 Most Recent Split Date: 6.00 (0.20:1) Beta: 1.58 Market Capitalization: $100.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.47 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 1.39 EPS Growth vs. Year Ago Period: 25.81% vs. Previous Quarter: -21.05% Sales Growth vs. Year Ago Period: -12.71% vs. Previous Quarter: -7.36% ROE 09/30/25 - - 06/30/25 - - 03/31/25 - -632.62 ROA 09/30/25 - -71.64 06/30/25 - -71.52 03/31/25 - -71.72 Current Ratio 09/30/25 - 0.67 06/30/25 - 0.58 03/31/25 - 2.09 Quick Ratio 09/30/25 - 0.55 06/30/25 - 0.46 03/31/25 - 1.72 Operating Margin 09/30/25 - -67.07 06/30/25 - -68.87 03/31/25 - -79.61 Net Margin 09/30/25 - -67.07 06/30/25 - -68.87 03/31/25 - -79.61 Pre-Tax Margin 09/30/25 - -67.00 06/30/25 - -68.87 03/31/25 - -79.56 Book Value 09/30/25 - -0.25 06/30/25 - -0.49 03/31/25 - -0.17 Inventory Turnover 09/30/25 - 1.55 06/30/25 - 1.60 03/31/25 - 1.46 Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - -

Powered by Zacks Investment Research ©